Maria C. Lobo
London, ENG SE58AF, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Immune alterations in schizophrenia and the effects of a therapeutic antibody: a neuroimaging study.
Immune alterations in schizophrenia and the effects of a therapeutic antibody: a neuroimaging study.
Journal: Brain : a journal of neurology
Published: July 01, 2025
The role of low subcortical iron, white matter myelin, and oligodendrocytes in schizophrenia: a quantitative susceptibility mapping and diffusion tensor imaging study.
Journal: Molecular psychiatry
Published: July 05, 2024
Immune response to vaccination in people with psychotic disorders relative to healthy controls: prospective study of SARS-CoV-2 vaccination.
Journal: BJPsych open
Published: February 16, 2024
New Drug Treatments for Schizophrenia: A Review of Approaches to Target Circuit Dysfunction.
Journal: Biological psychiatry
Published: December 29, 2023
Health Care Providers' Experiences of a Mandatory Nationwide Transition to an Adalimumab Biosimilar.
Health Care Providers' Experiences of a Mandatory Nationwide Transition to an Adalimumab Biosimilar.
Journal: ACR open rheumatology
Published: August 14, 2023
Rheumatology Patients' Experiences of a Mandatory Nationwide Transition to an Adalimumab Biosimilar.
Rheumatology Patients' Experiences of a Mandatory Nationwide Transition to an Adalimumab Biosimilar.
Journal: ACR open rheumatology
Published: July 28, 2023
Vortioxetine as adjunctive therapy in the treatment of schizophrenia.
Journal: Therapeutic advances in psychopharmacology
Published: February 03, 2022
Is Three a Crowd? The Influence of Companions on a Patient's Decision to Transition to a Biosimilar.
Is Three a Crowd? The Influence of Companions on a Patient's Decision to Transition to a Biosimilar.
Journal: Annals of behavioral medicine : a publication of the Society of Behavioral Medicine
Published: August 28, 2021
New and emerging treatments for schizophrenia: a narrative review of their pharmacology, efficacy and side effect profile relative to established antipsychotics.
Journal: Neuroscience and biobehavioral reviews
Published: June 14, 2021
The clinical significance of duration of untreated psychosis: an umbrella review and random-effects meta-analysis.
Journal: World psychiatry : official journal of the World Psychiatric Association (WPA)
Published: January 12, 2021
Patients' beliefs and behaviours are associated with perceptions of safety and concerns in a hypothetical biosimilar switch.
Journal: Rheumatology international
Published: February 11, 2020
Last Updated: 09/26/2026